Artemis Medicare Services Limited — PPTs, 05-02-2025: Investor Presentation

**1. Financial Highlights:**

Artemis Hospitals demonstrated solid performance in Q3 FY25 with gross revenue reaching ₹2,431 million, marking a 6.3% year-on-year increase. Net revenue from operations rose by 6.2% to ₹2,324 million. EBITDA for the quarter grew 34.4% to ₹463 million, pushing EBITDA margin to 19.9%. Notably, profit after tax surged 78.3% to ₹206 million.

**2. Strategic Initiatives and Growth Drivers:**

The company is optimizing its operations by improving efficiency and enhancing the patient experience, alongside a strategic partnership for advanced physiotherapy services. Emphasizing growth, Artemis plans to launch its Raipur facility within a year and expand its super-speciality services across key markets.

**3. Business Developments:**

Plans to ramp up occupancy in a newly opened tower suggest a focus on scaling operations. The expansion into Raipur marks a strategic entry into central India, alongside further investment in international healthcare facilities.

**4. Market Position and Competitive Advantage:**

Artemis is aligning with industry demand for high-quality, accessible healthcare, increasing its appeal in medical tourism and diversifying patient intake through a balanced payer mix.

**5. Investor Implications:**

With strong operational and financial metrics, Artemis's focus on quality care and strategic growth positions it favorably in the healthcare sector. Investors should watch closely for continued expansion and market share increases, indicating a positive outlook ahead.